Discover investment opportunities in Best Cheap Biotech Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Cheap Biotech Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Cheap Biotech Stocks using our Smart AI Filter.
8 stocks found for "Best Cheap Biotech Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.81 | ±48.4% | 14.1 | 0.00% | |||
1.49 | ±67.3% | -13.9 | 0.00% | |||
1.01 | ±62.0% | 25.4 | 0.00% | |||
0.86 | ±55.0% | 41.8 | 0.00% | |||
0.76 | ±41.4% | 25.6 | 0.00% | |||
2.30 | ±100.0% | -1.9 | 0.00% | |||
1.13 | ±100.0% | -0.1 | 0.00% | |||
1.70 | ±100.0% | -0.6 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What growth potential do biotech stocks like ACAD and XENE offer?
A: ACADIA Pharmaceuticals (ACAD) and Xenon Pharmaceuticals (XENE) are involved in drug development and have shown growth potential through partnerships and clinical successes. Historical data shows volatility in the biotech sector, but approved therapies and pipeline advancements may offer long-term growth opportunities.
Q: Are stocks like CTMX and CLVS attractive for dividend income?
A: CytomX Therapeutics (CTMX) and Clovis Oncology (CLVS) typically reinvest earnings into R&D, as is common in biotech, and do not focus on dividend distributions. Investors seeking income may look elsewhere, but may consider potential capital appreciation from successful drug developments.
Q: How do market cycles impact biotech companies like FGEN and NKTR?
A: Companies like FibroGen (FGEN) and Nektar Therapeutics (NKTR) can be greatly affected by market cycles, as market downturns may reduce funding and valuations. Conversely, technological advancements or favorable regulatory news can drive growth, emphasizing the importance of timing in biotech investments.
Q: What competitive advantages do companies like GRTS have in the biotech industry?
A: Gritstone Bio (GRTS) specializes in personalized cancer immunotherapies, providing a competitive edge through cutting-edge technology and partnerships. Biotech firms that focus on niche treatment areas often gain an advantage through innovation and collaborative efforts with larger pharma entities.
Q: How might geopolitical factors influence the biotechs BDSI and INFI?
A: BDSI (BioDelivery Sciences International) and Infinity Pharmaceuticals (INFI) may be impacted by geopolitical factors like regulatory changes in drug approval processes and international trade policies. Access to global markets can affect drug distribution and partnership opportunities, influencing revenue potential.
Q: Why are investors interested in LBIO and similar biotech stocks?
A: Iovance Biotherapeutics (LBIO) focuses on therapies for cancer treatment, attracting investors due to potential high returns from advances in biotechnology. While risky, successful trials and FDA approvals in this space can significantly boost stock performance, making LBIO an intriguing speculative play.